ACORN CAPITAL ADVISORS, LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$295.1B
Holdings
21
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TERNTERNS PHARMACEUTICALS INC | 1,746,264 | $70.5B | 23.90% | |
| 2 | CGONCG ONCOLOGY INC | 1,131,501 | $47.0B | 15.92% | |
| 3 | URGNUROGEN PHARMA LTD | 1,448,420 | $33.9B | 11.49% | |
| 4 | TRVITREVI THERAPEUTICS INC | 2,144,844 | $26.9B | 9.10% | |
| 5 | PBYIPUMA BIOTECHNOLOGY INC | 4,131,299 | $24.6B | 8.33% | |
| 6 | CADLCANDEL THERAPEUTICS INC | 2,580,517 | $14.6B | 4.94% | |
| 7 | HELPCYBIN INC | 1,573,023 | $12.9B | 4.36% | |
| 8 | VSTMVERASTEM INC | 1,469,153 | $11.3B | 3.84% | |
| 9 | BCAXBICARA THERAPEUTICS | 643,382 | $10.8B | 3.67% | |
| 10 | TARAPROTARA THERAPEUTICS INC | 1,752,115 | $9.3B | 3.16% | |
| 11 | OKURONKURE THERAPEUTICS INC | 2,839,674 | $8.2B | 2.79% | |
| 12 | CRDFCARDIF ONCOLOGY INC | 1,962,084 | $5.5B | 1.87% | |
| 13 | LONAATHIRA PHARMA INC. | 501,739 | $3.8B | 1.29% | |
| 14 | JSPRJASPER THERAPEUTICS | 1,786,492 | $3.3B | 1.11% | |
| 15 | AURAAURA BIOSCIENCES INC | 595,744 | $3.2B | 1.10% | |
| 16 | WHWKWHITEHAWK THERAPEUTICS INC | 1,139,363 | $2.8B | 0.93% | |
| 17 | BCABBIOATLA INC | 4,835,111 | $2.8B | 0.93% | |
| 18 | QTTBQ32 BIO INC. | 493,425 | $1.6B | 0.56% | |
| 19 | ASNSUSDX4 PHARMACEUTICALS INC | 273,349 | $1.1B | 0.37% | |
| 20 | ACRVACRIVON THERAPEUTICS INC | 405,237 | $976.0M | 0.33% | |
| 21 | VYNEVYNE THERAPEUTICS INC | 1,425 | $0 | 0.00% |